Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Issue navigator


 


Contents of Volume 12 Suppl 6
Severe community-acquired pneumonia update: mortality, mechanisms and medical intervention
Proceedings
from Severe community-acquired pneumonia update: mortality, mechanisms, and medical intervention
Barcelona, Spain. 21 April 2008
Edited by Steven Opal
Publication of this supplement has been sponsored by Novartis

Introduction    
Severe community acquired pneumonia update: mortality, mechanisms and medical intervention
Pierre-Francois Laterre
Critical Care 2008, 12(Suppl 6):S1 (26 November 2008)
[Full text] [PDF] [PubMed] [Related articles]

Review    
Demographics, guidelines, and clinical experience in severe community-acquired pneumonia
Jordi Rello
Critical Care 2008, 12(Suppl 6):S2 (26 November 2008)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Review    
Tissue factor as an initiator of coagulation and inflammation in the lung
Tom van der Poll
Critical Care 2008, 12(Suppl 6):S3 (26 November 2008)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Review    
Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition
Pierre-Francois Laterre
Critical Care 2008, 12(Suppl 6):S4 (26 November 2008)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Review    
The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy
Jean-Paul Mira, Adeline Max, Pierre-Regis Burgel
Critical Care 2008, 12(Suppl 6):S5 (26 November 2008)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

edit my details
Critical Care
BioMed Central
Current Controlled
Trials
PubMed
PubMed Central



© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.